Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention.

por Chaudhary, K S, Abel, P D, Lalani, E N
Publicado 1999

Comment on ‘Endocrine therapy in prostate cancer: time for re-appraisal of risks, benefits and cost-effectiveness?'

por Shah, S I A, Abel, P D, Langley, R E, Cafferty, F H
Publicado 2013

Altered phosphorylation status, phospholipid metabolism and gluconeogenesis in the host liver of rats with prostate cancer: a 31P magnetic resonance spectroscopy study.

por Dagnelie, P. C., Bell, J. D., Williams, S. C., Bates, T. E., Abel, P. D., Foster, C. S.
Publicado 1993